Causes of Hair Loss: A Medical Guide for Men and Women
Hair loss is one of the most distressing changes patients experience because it affects how they see themselves daily, every time they look in a mirror or run a comb through their hair. The cultural conversation around hair loss tends to oversimplify, with the typical advice falling into two camps: it is genetic and you cannot do anything, or it is stress and you should relax. The reality is that hair loss has multiple distinct medical causes, each with different patterns, different timelines, and different effective treatments. The single most important thing patients can do is identify which type of hair loss they actually have, because the right treatment depends entirely on the underlying cause.
This guide walks through the main medical causes of hair loss in men and women, the specific patterns that point to each cause, why some types respond well to treatment while others require different approaches, and when professional evaluation makes sense. By the end you will have a clearer sense of which pattern matches your specific situation and what your realistic options are.
Key takeaway: The major causes of hair loss fall into five categories: androgenetic alopecia (genetic pattern hair loss), telogen effluvium (stress-related shedding), alopecia areata (autoimmune patches), traction alopecia (tension damage), and medical or nutritional causes. Each has a different pattern, different timeline, and different treatments. At Tactus Health, our hair loss program treats men and women with combinations of PRP therapy, topical minoxidil, oral medications including finasteride, and other targeted protocols based on the underlying cause.
The Five Main Causes of Hair Loss
Hair loss is not a single condition but a category of conditions with different underlying mechanisms. Identifying which one is affecting you matters because the treatments that work for one type often do nothing for another, and pursuing the wrong treatment delays effective care while the underlying process continues.
Androgenetic alopecia is the genetic, hormone-driven pattern hair loss that affects roughly half of men by age 50 and a substantial portion of women, often becoming more visible after menopause. Telogen effluvium is a stress-related or hormone-shift-related diffuse shedding that typically resolves once the trigger is addressed. Alopecia areata is an autoimmune condition that creates discrete patches of hair loss. Traction alopecia results from chronic tension on the hair from tight styles or extensions. Medical and nutritional causes include thyroid disorders, iron deficiency, polycystic ovary syndrome, postpartum hormone shifts, certain medications, and several other systemic factors. Each requires its own approach, and many patients have a combination of two or more types contributing simultaneously.
Androgenetic Alopecia: Genetic Pattern Hair Loss
Androgenetic alopecia is the most common cause of hair loss in both men and women. The pattern is genetic, but the visible expression is driven by the conversion of testosterone to dihydrotestosterone (DHT), which gradually shrinks hair follicles in genetically susceptible patients. The follicles produce thinner, shorter, lighter hairs over multiple growth cycles, eventually producing nothing visible at the surface. The follicles themselves do not die immediately, which is why early intervention can preserve and sometimes regrow hair that has not yet been lost completely.
The pattern looks different in men and women. Men typically show recession at the temples, thinning at the crown, or both, often progressing over years to the classic horseshoe pattern. Women typically show diffuse thinning across the top of the scalp with a widening part, often described as Christmas-tree pattern thinning, with the hairline usually preserved. Some women develop more aggressive patterns particularly during perimenopause and after menopause when hormonal shifts amplify the genetic susceptibility. According to the American Academy of Dermatology, female pattern hair loss is significantly more common than most patients realize and tends to be underdiagnosed because the pattern is less recognizable than the male version.
Telogen Effluvium: Stress and Shock-Related Shedding
Telogen effluvium is the diffuse shedding that occurs when a significant proportion of scalp hair follicles enter the shedding phase simultaneously. The trigger is typically a major physiological stressor: severe illness, surgery, childbirth, rapid weight loss, hormonal shifts, severe emotional stress, or starting or stopping certain medications. The shedding becomes visible roughly two to three months after the triggering event because hair follicles take that long to cycle from the trigger to visible loss. Patients describe finding hair on their pillow, in the shower, and on their hairbrush in volumes that did not exist before.
The good news with telogen effluvium is that it is typically self-limiting once the underlying trigger is addressed. The follicles remain healthy and resume normal growth once the stress passes. The shedding usually continues for three to six months, with regrowth becoming visible over the following year. The challenging part is that during the active shedding phase, patients lose volume that takes a year or more to replace. Identifying and addressing the trigger is the priority, with supportive care including good nutrition, stress management, and sometimes topical treatments to support regrowth.
Alopecia Areata: Autoimmune Patches
Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, producing discrete round patches of complete hair loss. The patches typically appear suddenly, are smooth and shiny in appearance, and may be accompanied by short broken hairs at the borders. The condition can affect any hair-bearing area of the body and can range from a single patch that resolves on its own to extensive forms including complete loss of scalp hair (alopecia totalis) or all body hair (alopecia universalis).
The pattern of alopecia areata is distinctive and usually identifiable by examination. Treatment options include topical and injected corticosteroids for limited disease, systemic immunomodulating treatments for more extensive disease, and increasingly newer JAK inhibitor medications that have shown impressive results in clinical trials for severe forms. Spontaneous regrowth occurs in many patients, particularly with limited single-patch presentations. Patients with alopecia areata benefit significantly from medical evaluation because the treatment is fundamentally different from other hair loss types.
Traction Alopecia: Tension Damage From Styling
Traction alopecia results from chronic tension on the hair from tight styling practices, hair extensions, weaves, braids, ponytails, or any other practice that pulls on the hair root over time. The pattern typically appears at the hairline, the temples, or wherever tension is concentrated. Early traction alopecia is reversible if the tension source is removed before the follicles are permanently damaged. Late-stage traction alopecia produces scarring and follicle destruction that does not respond to treatment, making early identification critical.
Patients who use hair extensions, wear tight ponytails or buns daily, or have any styling pattern that pulls on the scalp should monitor for early signs including small bumps along the hairline, tenderness at the scalp, broken hairs at tension points, and gradual recession of the hairline. Stopping or modifying the tension-creating practice is the foundational treatment, and earlier intervention produces dramatically better outcomes than waiting until the follicles are damaged. This form of hair loss is one of the most preventable but also one of the most commonly underrecognized causes.
Medical and Nutritional Causes
Several systemic conditions can produce hair loss as part of their broader effects, and identifying these causes matters because the hair loss often resolves once the underlying condition is treated. Thyroid disorders (both hyperthyroid and hypothyroid) commonly produce diffuse hair thinning. Iron deficiency anemia is a common cause of hair loss in women, particularly those with heavy menstrual cycles. Polycystic ovary syndrome (PCOS) contributes to female pattern hair loss through its androgen elevation effects. Postpartum hormonal shifts produce a characteristic shedding pattern around three to four months after delivery. Severe nutritional deficiencies including protein, vitamin D, B12, and zinc can affect hair quality.
Several medications can cause hair loss as a side effect including blood thinners, beta blockers, certain antidepressants, oral contraceptives in some patients, and chemotherapy agents. Identifying medication-related hair loss requires careful timeline review because the loss often appears two to three months after starting the medication. A consultation with a provider includes a comprehensive review of medical history, current medications, and relevant lab work to identify any contributing factors that need addressing alongside or instead of direct hair loss treatment.
How Tactus Health Treats Hair Loss
Tactus Health offers a comprehensive hair loss program covering both men and women, with treatment plans matched to the specific cause and pattern of each patient’s hair loss. PRP therapy uses growth factors from the patient’s own blood to stimulate dormant follicles and improve the quality of existing hair, with results developing over a series of monthly treatments. Topical minoxidil is offered for both genders as a first-line foundation treatment, with prescription-strength formulations available when over-the-counter concentrations are insufficient. Oral finasteride is offered for men with androgenetic alopecia and is one of the most effective treatments available for the male pattern. Women have additional treatment options that vary based on hormonal status, age, and specific clinical pattern.
The program emphasizes accurate diagnosis before treatment. A consultation includes detailed history, scalp examination, photography to document baseline appearance, and laboratory evaluation when systemic causes are possible. The treatment plan flows from the diagnosis. Patients with androgenetic alopecia receive different treatment than patients with telogen effluvium, and both receive different treatment than patients with thyroid-related hair loss. Generic one-size-fits-all hair loss treatment without a clear diagnosis is one of the most common reasons patients fail to see results elsewhere, and our program is designed to avoid that pattern.
When to See a Provider for Hair Loss
Several signals make professional evaluation worthwhile rather than continuing to manage hair loss on your own. Sudden or rapidly progressing hair loss warrants prompt evaluation because the rate of change often points to specific identifiable causes. Patches of complete hair loss on the scalp suggest alopecia areata or other localized causes that benefit significantly from medical treatment. Hair loss accompanied by other symptoms (fatigue, weight changes, menstrual irregularities, skin changes) suggests possible systemic causes that warrant lab evaluation. Hair loss that has been progressing for years without successful at-home management benefits from a structured medical approach with treatments that produce better results than over-the-counter products alone.
For androgenetic alopecia specifically, earlier intervention produces significantly better outcomes than waiting until the loss is advanced. The follicles that are still producing visible hair, even thinner versions, can typically be preserved and sometimes improved with treatment. Follicles that have been completely dormant for years are much harder to revive. The patients who get the best long-term results from hair loss treatment are typically those who started intervention in the early stages of pattern hair loss rather than waiting until the loss was substantial.
Important note about hair loss treatment timelines: hair grows slowly, which means any hair loss treatment requires patience to evaluate. Most effective treatments take three to six months to show meaningful visible results, with continued improvement over the following year. According to the American Academy of Dermatology, patients should evaluate hair loss treatments at the six-month mark and the twelve-month mark rather than abandoning protocols early because results were not immediately visible. Consistency over months produces results that no single treatment can deliver in weeks.
- Androgenetic alopecia
- The medical name for genetic, hormone-driven pattern hair loss. The most common cause of hair loss in both men and women. Driven by DHT-mediated follicle shrinkage in genetically susceptible patients.
- Telogen effluvium
- Diffuse hair shedding triggered by a major physiological or emotional stressor. Typically self-limiting once the trigger is addressed, with regrowth over the following year.
- Alopecia areata
- An autoimmune condition producing discrete round patches of complete hair loss. Distinct in pattern from other hair loss types and treated with different protocols.
- Traction alopecia
- Hair loss caused by chronic tension on the hair root from tight styles, extensions, or other tension-creating practices. Reversible early; permanent if not addressed before follicle damage.
- Dihydrotestosterone (DHT)
- A hormone derived from testosterone that drives follicle shrinkage in androgenetic alopecia. The target of finasteride treatment for male pattern hair loss.
Free consultation in Sugar Hill, GA. Our hair loss program treats men and women with PRP therapy, topical minoxidil, oral medications including finasteride, and protocols matched to your specific cause and pattern. Accurate diagnosis before treatment.
Book Free Consultation